Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ringer's Acetate vs Normal Saline in Sepsis
NCT03277677Phase 3Completed
- Sponsor
- Chulalongkorn University
- Start
- Jul 2017
- Primary completion
- Jul 2018
- Countries
- 1
01
Overview
Phase 3, randomised trial of ringer's acetate in sepsis and septic shock, sponsored by Chulalongkorn University. Primary endpoint: Incidence of acute kidney injury at 7 days. Started Jul 2017; status: completed.
02
Drugs
ringer's acetate
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT03277677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03277677.